SPY - relatively flat this morning after two days of selling strength from Powell's hawkish testimony. Late in the session we had a ripping rally which quickly corrected to the downside in the after hours. To me this means that it flushed out some late shorts but the bears were still in control. Leaning slightly bearish for the day but not expecting any large...
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed...
NASDAQ:CLNN
Possible Scenario: SHORT
Evidence: Price Action, Money Flow
TP1: 3.05$
TP2: 2.5$
Put option 16 Sep 2022, Strike 2.5$, current bid-ask 0.70$/0.75$
*This is my idea and could be wrong 100%.
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
CLNN broke resistance
Above 200 EMA
